Control of therapy of acne papulopustulosa by visible light with waterfiltered infrared and / or Adapalen (Differin Gel)

• Conditions: Acne papulopustulos

• Registration Number: EUCTR2005-004640-31-DE
• Lead Sponsor: Technische Universität Dresden

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2005-12-23
• Last Update Posted: 19 March 2012

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Age >= 14 years
Mild to moderate acne papulopustulosa according to Burton Scale Stage 3 to 4
At least 5 inflammatory and 5 non-inflammatory lesions in the face
Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Pregnant and nursin women
Antiandrogen therapy
Therapy with antibiotics within the last 4 weeks
Therapy with retinoids within the last 6 months.
Natural or artificial UV-therapy within the last 4 weeks
Severe acne papulopustulosa according to Burton Scale 5 or 6
Severe systemic condition
Alcohol or drug abuse
Noncompliant patients
Use of other acne therapeutics 2 weeks before and during the study
Secondyry acne (for example chlor and steroid acne)

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Main Objective: Control of the effectiveness of visible light in combination with infrared light compared to Adapalen (Differin Gel);Secondary Objective: ;Primary end point(s): Reduction of inflammatory and non-inflammatory lewsions within 8 weeks after start of therapy.